SRD

Sara R. Dasse Portfolio

Invests via Adams Street Partners LLC | Managed by Jeffrey Diehl, Miguel Gonzalo, CFA, Ervis Vukaj
Invests via Adams Street Partners LLC
Managed by Jeffrey Diehl, Miguel Gonzalo, CFA, Ervis Vukaj
Automatically Tracked
Tracking: 0 Updated: Yesterday at 02:00 PM
Sara R. Dasse Profile

As a seasoned entrepreneur, Sara R. Dasse has established herself as a pivotal figure in the tech landscape. With deep expertise in product innovation and market strategy, she has successfully launched multiple startups that leverage cutting-edge technology to enhance user experiences. Her journey reflects a commitment to driving growth through creative solutions and adaptive leadership. Recognized for her strategic insights, Dasse is also engaged in mentoring emerging founders, fostering an environment where innovative ideas can thrive. Through these endeavors, she continues to influence the entrepreneurial ecosystem and create meaningful connections within the industry.

As a seasoned entrepreneur, Sara R. Dasse has established herself as a pivotal figure in the tech landscape. With deep expertise in product innovation and market strategy, she has successfully launched multiple startups that leverage cutting-edge technology to enhance user experiences. Her journey reflects a commitment to driving growth through creative solutions and adaptive leadership. Recognized for her strategic insights, Dasse is also engaged in mentoring emerging founders, fostering an environment where innovative ideas can thrive. Through these endeavors, she continues to influence the entrepreneurial ecosystem and create meaningful connections within the industry.

Investment Philosophy & Strategy

Innovation drives the investments and business decisions of Sara R. Dasse, who thrives at the intersection of technology and entrepreneurship. Her extensive background in product innovation informs her approach to identifying transformative opportunities within emerging markets. Focused on harnessing disruptive ideas, she often seeks to align capital with ventures that have the potential for significant user impact. By fostering collaboration among nascent tech leaders, she cultivates a rich ecosystem that enhances competitive positioning and accelerates growth trajectories across sectors. Dasse's commitment to mentoring exemplifies her belief in empowering others to realize their vision through strategic execution.

Innovation drives the investments and business decisions of Sara R. Dasse, who thrives at the intersection of technology and entrepreneurship. Her extensive background in product innovation informs her approach to identifying transformative opportunities within emerging markets. Focused on harnessing disruptive ideas, she often seeks to align capital with ventures that have the potential for significant user impact. By fostering collaboration among nascent tech leaders, she cultivates a rich ecosystem that enhances competitive positioning and accelerates growth trajectories across sectors. Dasse's commitment to mentoring exemplifies her belief in empowering others to realize their vision through strategic execution.

Disclaimer: This Portfolio is derived from and computed based on publicly available data from SEC filings.
Gain and growth charts are calculated per selected timeframe:
219.53%
Gain +1.41%
Monthly
1.05%
Yearly
13.41%
Drawdown
50%
$634.37M
Equity
Holdings
$634.37M
Investment
$580.9M
$727.26M
Profit +$856,177.86
Realized
$673.78M
Unrealized
$53.47M
Dividends
$23.82M

Goals

Avg. 0% completed goals
Today
Compared To Yesterday
Gain
1.41%
Profit
$856,177.86
Win %
50%
This Week
Compared To Last Week
Gain
0.74%
Profit
$4.67M
Win %
50%
This Month
Compared to last month
Gain
-1.49%
Profit
-$9.56M
Win %
50%
This Year
Compared to last year
Gain
-11.89%
Profit
$25.04M
Win %
48%
Cerebras Systems Inc. logo
CBRS Cerebras Systems Inc.
+3.52%
+$2.72M
TransDigm Group Inc. logo
TDG TransDigm Group Inc.
+0.52%
+$328,364.12
Rimini Street Inc. logo
RMNI Rimini Street Inc.
+0.47%
+$485,447.92
Infinera Corporation logo
INFN Infinera Corporation
0%
$0
Citrix Systems Inc logo
CTXS Citrix Systems Inc
0%
$0
PCS
PCS
0%
$0
SVVS
SVVS
0%
$0
PHRM
PHRM
0%
$0
SPRD
SPRD
0%
$0
ARUN
ARUN
0%
$0
CRXX
CRXX
0%
$0
CAVM
CAVM
0%
$0
CYCL
CYCL
0%
$0
CBEY
CBEY
0%
$0
FTWR
FTWR
0%
$0
DDUP
DDUP
0%
$0
NXTM
NXTM
0%
$0
Comscore Inc. logo
SCOR Comscore Inc.
-2.64%
-$11,482.8
Corvus Pharmaceuticals Inc. logo
CRVS Corvus Pharmaceuticals Inc.
-1.83%
-$753,391.68
BillionToOne, Inc. logo
BLLN BillionToOne, Inc.
-1.81%
-$3.42M
Jazz Pharmaceuticals plc logo
JAZZ Jazz Pharmaceuticals plc
-0.8%
-$773,308.66
Xtant Medical Holdings Inc. logo
XTNT Xtant Medical Holdings Inc.
-0.17%
-$3.85
Loading...

Dividends

Dividend Analysis

Yearly
$
Trades
564
Longs Won
200/564 35%
Profit Factor
3.35
Profitability
Shorts Won
0/0 0%
Standard Deviation
$8.63M
Average Win
$5.19M
Best Trade
(Jun 30) $70.34M
Sharpe Ratio
-2.29
Average Loss
-$851,671.46
Worst Trade
(Sep 18) -$46.31M
Z-Score
-5.22 (100%)
Commissions
$0
Avg. Trade Length
1y 10m 2d
Expectancy
$1.29M
Loss Size 100% 90% 80% 70% 60% 50% 40% 30% 20% 10%
Probability of Loss <0.01% <0.01% <0.01% <0.01% <0.01% <0.01% <0.01% 0.04% 0.77% 10.04%
Consecutive Losing Trades 745 670 596 521 447 372 298 223 149 74
Hover over the desired column for a detailed explanation.

Returns

Overall, Monthly
Symbol Quantity Cost Value Comm. Profit (&#36;) Gain (%) Change
ARUN
ARUN
97,415 $1.21M $1.45M - $242,212.08 20.02%
0.0
BillionToOne, Inc. logo
BLLN BillionToOne, Inc.
1.71M $140.06M $185.98M - $45.92M 32.78%
-1.807%
CAVM
CAVM
126,173 $2.9M $2.9M - - -
0.0
CBEY
CBEY
700,000 $10.27M $11.21M - $940,067.77 9.15%
0.0
Cerebras Systems Inc. logo
CBRS Cerebras Systems Inc.
398,144 $87.99M $80.02M - -$7.97M -9.06%
+3.523%
Corvus Pharmaceuticals Inc. logo
CRVS Corvus Pharmaceuticals Inc.
3.28M $45.63M $40.36M - -$5.28M -11.56%
-1.833%
CRXX
CRXX
720,674 $2.56M $2.56M - - -
0.0
Citrix Systems Inc logo
CTXS Citrix Systems Inc
93,022.8 $2.72M $3.54M - $816,013.33 30%
0.0
CYCL
CYCL
30,000 $279,000 $279,000 - - -
0.0
DDUP
DDUP
17,426 $459,000 $459,000 - - -
0.0
FTWR
FTWR
17,797 $41,000 $41,000 - - -
0.0
Infinera Corporation logo
INFN Infinera Corporation
41,173 $611,000 $611,000 - - -
0.0
Jazz Pharmaceuticals plc logo
JAZZ Jazz Pharmaceuticals plc
397,588 $2.58M $96.17M - $93.59M 3,627.13%
-0.798%
NXTM
NXTM
746,903 $2.91M $2.87M - -$46,503.08 -1.6%
0.0
PCS
PCS
1.74M $33.28M $33.9M - $613,478.67 1.84%
0.0
PHRM
PHRM
63,921 $4.02M $4.02M - - -
0.0
Rimini Street Inc. logo
RMNI Rimini Street Inc.
23.57M $192.12M $103.23M - -$88.89M -46.27%
+0.472%
Comscore Inc. logo
SCOR Comscore Inc.
85,057.8 $39.99M $423,162.55 - -$39.57M -98.94%
-2.642%
SPRD
SPRD
57,688 $707,000 $707,000 - - -
0.0
SVVS
SVVS
42,779 $837,160.92 $552,000 - -$285,160.92 -34.06%
0.0
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
FAQ
Which stocks have generated the highest profits for Sara R. Dasse?
The largest contributions to the portfolio's profits come from the following stocks: Paylocity Holding Corporation - $450.41M, Q2 Holdings Inc - $183.54M, Five9 Inc - $66.01M, TransDigm Group Inc - $29.5M, and Coinbase Global, Inc - $21.72M. These positions have been the main drivers of growth and have significantly impacted the investor's overall performance.
Which stocks have generated the largest losses for this investor?
The largest losses in the portfolio are associated with the following stocks: Robinhood Markets, Inc - $36.01M, CBEY - $20.16M, Comscore Inc - $15.89M, Rimini Street Inc - $13.54M, and Mineralys Therapeutics, Inc - $8.32M. These positions have had the most negative impact on overall performance and highlight the weaker areas of the portfolio.
What dividends does Sara R. Dasse's portfolio generate?
The portfolio generates substantial dividend income, with a total of $23.82M earned over time. The largest contributors to dividend income include TransDigm Group Inc - $23.01M, Citrix Systems Inc - $430,695.58, Sabre Corporation - $198,136.51, Fidelity National Information Services, Inc - $40,752.14, and Buckeye Partners LP - $31,827. This indicates that dividends play a meaningful role in the investor's overall strategy.
How stable are Sara R. Dasse's monthly returns?
Sara R. Dasse's monthly returns look highly volatile. The portfolio shows large month-to-month swings, and the broader risk profile suggests that performance can change sharply over short periods. This kind of pattern may suit users who are comfortable with significant fluctuations, but it is less likely to appeal to those who prefer steadier and more predictable results.
Can Sara R. Dasse's strategy be considered aggressive or moderate?
Sara R. Dasse's strategy can be considered aggressive. The combination of high drawdowns, elevated volatility, and/or concentrated positions suggests a willingness to accept significant risk in pursuit of higher long-term returns. This approach is generally more suitable for users who are comfortable with large fluctuations in portfolio value.
Should beginners follow Sara R. Dasse's strategy?
Sara R. Dasse's strategy is unlikely to be suitable for beginners. The portfolio shows signs of high risk, significant volatility, or structural complexity, which can make it difficult to follow and potentially stressful for less experienced users. This type of approach is generally better suited to more advanced investors.
Account USV